Breast Cancer Screening Market Share 2022 COVID-19 Impact and Regional Outlook 2030

description
The global breast cancer screening market size is projected to be US$5.2 billion in 2021 and reach US$8.43 billion in 2027, growing at a CAGR of 8.4% during the forecast period 2021-2027. Breast cancer remains the most common cancer worldwide and is one of the most common diseases affecting women aged 50-70, underscoring the urgent need for effective breast cancer screening. Women are increasingly aware of the signs and symptoms of breast cancer, along with how early screening and diagnosis can prevent further adverse episodes. This is expected to be one of the key factors driving market growth over the forecast period. Amidst an alarming prevalence rate of cancer, governments worldwide have launched several initiatives in favor of effective early detection, diagnosis and treatment that will greatly support the growth of the breast cancer screening market. Imaging techniques are currently trending in the global breast cancer screening market.

Get PDF for more professional and technical insights: https://www.marketstatsville.com/request-sample/breast-cancer-screening-market

Key factors to be accountable in shaping the Breast Cancer Screening industry during the forecast period
Factors such as increasing healthcare spending in developing countries, high prevalence of breast cancer and growing awareness of rising patient health concerns are expected to drive the growth of the global breast cancer screening market. The American Cancer Society estimates that over 280,000 new cases of breast cancer will be diagnosed in 2021 alone. In addition, almost 50,000 breast cancer-related deaths were expected in the United States alone. The WHO also emphasizes that breast cancer will become the most common cancer worldwide and expects a massive increase in prevalence and mortality. Breast cancer screening is therefore likely to remain in demand throughout the forecast period.

With the launch of technologically advanced, innovative screening products aimed at faster, more accurate and more cost-effective results, the breast cancer screening market will experience robust growth prospects. The introduction of direct-to-consumer (DTC) tests in the field of cancer diagnostics by 23andMe (2018) is likely to be largely responsible for the market growth. Favorable reimbursement scenarios and improved insurance coverage, particularly in developed western regions, will drive the adoption rate of breast cancer screening. The development of new screening tests and procedures such as physical tests, laboratory tests, imaging tests and genetic tests has positively influenced the demand for breast cancer screening in the healthcare and pharmaceutical sectors worldwide.

The various initiatives taken by governments and private medical institutions as well as NGOs/public organizations to promote breast cancer awareness is likely to be a powerful factor that boosts the market growth. The high cost of early detection tests and strict regulations governing the approval of early detection devices may limit the uptake of breast cancer screening tests to some extent.

Impact of COVID-19 on the Breast Cancer Screening Market
The global COVID-19 pandemic suddenly increased the burden on the healthcare system, leading to strained healthcare services for more than a year. During this critical period, breast cancer diagnosis, including mammography screening and treatment procedures, have been interrupted or performed at reduced capacity or delayed. This has had a significant adverse impact on the breast cancer screening market throughout 2020. In addition, the scenario further resulted in a delay in breast cancer diagnosis and treatment, potentially leading to intensive treatment requirements sooner or later and even an increase in the associated mortality rate in 2020 worst cases.

You can purchase the full report: https://www.marketstatsville.com/buy-now/breast-cancer-screening-market?opt=2950

Report Scope
The report outlines the global Breast Cancer Screening Market study based on type and end-user.

The Breast Cancer Screening Market has been segmented by Test Type -
Physical Tests
Laboratory Tests
Imaging Tests
Genetic Tests
The Breast Cancer Screening Market has been segmented based on End User -
Research Laboratories
Cancer Institutes
Diagnostic Centers
Other
Regional Outlook for the Breast Cancer Screening Market
Based on region, the global breast cancer screening market has been segmented into five geographic regions namely North America, Asia Pacific, Europe, South America, Middle East and Africa. In 2020, North America held the largest share of the breast cancer screening market, followed by Asia Pacific. Europe also remains an important market due to growing healthcare spending and technological advances in the region. Furthermore, Asia-Pacific is expected to project the world's highest CAGR over the forecast period due to the rapidly developing medical structure and rising healthcare spending in the region.

Major competitors in the global breast cancer screening market include:
Breast cancer screening

The market is highly fragmented, with the presence of a large number of small players around the world. The major manufacturers in Breast Cancer Screening Market operating in the global market are -

Siemens Healthcare
Allengers Infotech
Hologic, Inc. Myriad
Genetics
Metabolomic Technologies Inc.
Biocrates LifeSciences AG
A&G Pharma
Provista Diagnostics, Inc.
Roche Diagnostics
POC Medical Systems
BioTime, Inc.
General Electricity Company
Quest Diagnostics
Agendia NV
OncoCyte Corporation.

Access Full Report Description, TOC, Figures Table, Chart etc : https://www.marketstatsville.com/table-of-content/breast-cancer-screening-market

The Breast Cancer Screening Market report provides thorough analysis of macroeconomic factors and market attractiveness of each segment. The report will provide an in-depth qualitative and quantitative assessment of the segmental/regional prospects with the presence of market players in each segment and each region/country. The information completed in the report includes the inputs.

Breast Cancer Screening Market report covers comprehensive analysis of
market segmentation and regional analysis
10-year market size
Pricing analysis
Supply and demand analysis
Product life cycle analysis
Porter's five forces and value chain
analysis Developed and emerging markets
analysis PEST analysis
Market and forecast
factor analysis Market opportunities, risks and trends
Conclusion & Recommendation
Regulatory
Landscape Patent Analysis
Competitive
Landscape 15+ Company
Profiles Breast Cancer Screening Market Regional Analysis Covers
North America (United States, Canada, Mexico)
South America (Brazil, Argentina, Colombia, Peru, rest of Latin America)
Europe (Germany, Italy, France, UK, Spain, Poland, Russia, Slovenia, Slovakia, Hungary, Czech Republic, Belgium, Netherlands, Norway, Sweden, Denmark, rest of Europe )
Asia Pacific (China, Japan, India, South Korea, Indonesia, Malaysia, Thailand, Vietnam, Myanmar, Cambodia, Philippines, Singapore, Australia and New Zealand, rest of Asia Pacific)

The Middle East and Africa (Saudi Arabia, UAE, South Africa, North Africa, Rest of MEA
Breast Cancer Screening Market Target Breast Cancer Screening Clinics
and Diagnostic Centers
Investors and Trade Experts
Large, Medium and Small Businesses
Hospitals and Clinics
Specialist Publications and Magazines
Governments, Associations and Organizations

Request For Report Description:

Contact US:
Eric Martin
416, East standsberry street,
Perkins, Oklahoma 74059, US
USA: +1-580-205-2707 | India: +91-702-496-8807
Email: sales@marketstatsville.com
MSG Blog https://marketstatsvilleblogs.com/
Web: https://marketstatsville.com/

About US:
Market Statsville Group (MSG) partners with companies and society to confront their essential risks and challenges to capture the enormous opportunities for them. MSG initiated its work in 2017, and since then, the brand is moving to become a pioneer in business advisory and market research services.
We the leading market research and strategy builder with the depth and breadth of solutions that perfectly suit your every need. MSG provides solutions in a wide range of industry verticals in market sizing, analysis, and incisive business insights. MSG experienced research analysts are proficient at digging deep and providing various customizable data that help you make decisions with clarity, confidence, and impact.

This release was published on openPR.